Circulating autoantibodies in patients with aspirin-intolerant asthma: An epiphenomenon related to airway inflammation

Journal of Korean Medical Science

Volumn 21, Issue 3, 2006, Pages 412-417

  Ye, Young Min ^a   Nahm, Dong Ho ^a   Kim, Sang Ha ^a   Kim, Seung Hyun ^a   Choi, Jeong Hee ^b   Suh, Chang Hee ^a   Park, Hae Sim ^a  

^a Ajou University School of Medicine   (South Korea)

^b Bundang Jesaeng Hospital   (South Korea)

Author keywords

Aspirin; Aspirin intolerant Asthma; Autoantibodies; Bronchoconstriction; Cytokeratin; Keratin

Indexed keywords

EID: 33745247171     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.3.412     Document Type: Article

References (27)

1. Park HS. Aspirin-sensitive asthma. BioDrugs 2000; 13: 29-33.
2. Park HS, Cho YH, Kim SS, Kim HY, Nahm DH, Suh CH, Hahn MH. Prevalence of sensitivity to aspirin (ASA) and food additives in subjects diagnosed as having intrinsic asthma. J Asthma Allergy Clin Immunol 1998; 18: 662-71.
3. Delaney JC. The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 1976; 6: 177-81.
4. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000; 16: 432-6.
5. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111: 913-21.
6. Jawien J. A new insight into aspirin-induced asthma. Eur J Clin Invest 2002; 32: 134-8.
7. Venter JC, Fraser CM, Harrison LC. Autoantibodies to beta2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma. Science 1980; 207: 1361-3.
8. Menon P, Menon V, Hilman BC, Wolf R, Bairnsfather L. Antinuclear antibodies and anticytoplasmic antibodies in bronchial asthma. J Allergy Clin Immunol 1989; 84: 937-43.
9. Szczeklik A, Nizankowska E, Serafin A, Dyczek A, Duplaga M, Musial J. Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med 1995; 152: 1753-6.
10. Choi JH, Lee KW, Oh HB, Lee KJ, Suh YJ, Park CS, Park HS. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J Allergy Clin Immunol 2004; 113: 562-4.
11. Dekker JW, Nizankowska E, Schmitz-Schumann M, Pile K, Bochenek G, Dyczek A, Cookson WO, Szczeklik A. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy 1997; 27: 574-7.
12. Nahm DH, Lee YE, Yim EJ, Park HS, Yim HE, Kan Y, Kim JK. Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma. Am J Respir Crit Care Med 2002; 165: 1536-9.
13. Micheli L, Cerretani D, Fiaschi AI, Giorgi G, Romeo MR, Runci FM. Effect of acetaminophen on glutathione levels in rat testis and lung. Environ Health Perspect 1994; 102 (Suppl 9): 63-4.
14. Bucchier F, Puddicombe SM, Lordan JL, Richter A, Buchanan D, Wilson SJ, Ward J, Zummo G, Howarth PH, Djukanovic R, Holgate ST, Davies DE. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol 2002; 27: 179-85.
15. Caulin C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997; 22: 379-94.
16. Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, Bjorklund P, Ramaekers FC, Bjorklund B, Nap M, Jornvall H, Schutte B. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 1999; 187: 567-72.
17. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histology 2002; 40: 403-39.
18. Wisnewski AV, Srivastava R, Herick C, Xu L, Lemus R, Cain H, Magoski NM, Karol MH, Bottomly K, Redlich CA. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med 2000; 162: 2330-6.
19. Choi JH, Nahm DH, Kim SH, Kim YS, Suh CH, Park HS, Ahn SW. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma. Ann Allergy Asthma Immunol 2004; 93: 293-8.
20. Schutte B, Henfling M, Kolgen W, Bouman M, Meex S, Leers MP, Nap M, Bjorklund V, Bjorklund P, Bjorklund B, Lane EB, Omary MB, Jornvall H, Ramaekers FC. Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res 2004; 297: 11-26.
21. Hintner H, Romani N, Stanzl U, Grubauner G, Fritsck P, Lawley TJ. Phagocytosis of keratin filament aggregates following opsonization with IgG-anti-keratin filament autoantibodies. J Invest Dermatol 1987; 88: 176-82.
22. Szczeklik A. Aspirin-induced asthma as a viral disease. Clin Allergy 1988; 18: 15-20.
23. Martinet N, Bonnard L, Regnault V, Picard E, Burke L, Siat J, Grosdidier G, Martinet Y, Vignaud JM. In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer. Am J Respir Cell Mol Biol 2003; 28: 428-35.
24. Griffin M, Casadio R, Bergamini CM. Transglutaminases: Nature's biological glues. Biochem J 2002; 368: 377-96.
25. Dobashi N, Fujita J, Murota M, Ohtsuki Y, Yamadori I, Yoshinouchi T, Ueda R, Bandoh S, Kamei T, Nishioka M, Ishida T, Takahara J. Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis. Lung 2000; 178: 171-9.
26. Blobel GA, Moll R, Franke WW, Vogt-Moykopf I. Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 45: 407-29.
27. Murota M, Nishioka M, Fujita J, Dobashi N, Wu F, Ohtsuki Y, Hojo S, Takahara J, Kuriyama S. Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis. Clin Exp Immunol 2001; 125: 291-9.